You must log in to view this page.

Crinetics Pharmaceuticals Inc. – Indentures

NASDAQ: CRNX
Share price (8/10/26): $84.15
Market cap (8/10/26): $8.925 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Indentures Filter

EX-4.4

from S-3ASR 52 pages Crinetics Pharmaceuticals, Inc. Indenture Dated as of , 20 [ ] Trustee

12/34/56

EX-4.3

from 10-K 5 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934

12/34/56

EX-4.3

from 10-K 5 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934

12/34/56

EX-4.4

from S-3 51 pages Crinetics Pharmaceuticals, Inc. Indenture Dated as of , 20 [ ] Trustee

12/34/56

EX-4.1

from S-1/A 2 pages Indenture or similar

12/34/56

EX-4.2

from S-1 33 pages Crinetics Pharmaceuticals, Inc. Amended and Restated Investor Rights Agreement

12/34/56

EX-4.2

from DRS 33 pages Crinetics Pharmaceuticals, Inc. Amended and Restated Investor Rights Agreement

12/34/56

Crinetics Pharmaceuticals Inc. – Indentures Watch

Search in Documents

Key Exhibits

External Links

Indentures Filter

Crinetics Pharmaceuticals Inc. – Indentures